Tuesday, March 13, 2012

Quick post on some of my recent Los Angeles Times articles:

In November 2011, the FDA withdrew its approval for using the drug Avastin in patients with metastatic breast cancer.  Now, two new studies suggest the drug might be helpful in early stage breast cancer.  I parse that confusing message here.

The FDA reneges on one action to reduce antibiotic use in food animals, then moves forward on another. But the agency asserts that both decisions were made in the interest of preserving antibiotics that are medically important for humans. Here's the story.

Health and Human Services secretary Kathleen Sebelius overruled a decision by FDA commissioner Margaret Hamburg to make the so-called morning after pill available without a prescription.  Both parties cite science as basis for their opposing decisions on Plan B. I dig into that science here.

Common sense improvements proposed for school lunches devolve into food vs food fights. For instance, should 1/8 cup tomato paste be counted as a 1/2 cup serving because it's concentrated?